Delayed release treatment

Israeli biotech Intec has signed a deal with a major (but unnamed) international company worth $150 million to distribute Intec’s treatment for mental and neurological diseases. The delayed release treatment remains intact until it reaches the intestines, in order to release more effectively into the body.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *